InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (2 ops.)
Browse the complete record of transactions filed by Peetz Christopher, Chairman & CEO. Officer active across 3 companies, notably Mirum Pharmaceuticals, Inc.. In total, 13 disclosures have been logged. Total volume traded: €245k. The latest transaction was disclosed on 10 May 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations13 total
€19,3191,500 shares@ €12.87960.0005% mcap8.3% of flow
Common STock
SEC:0001209191-22-028722:0·
040,000 shares0
Common Stock
SEC:0001209191-22-002429·
040,000 shares0
Common Stock
SEC:0001209191-22-002429:0·
€89,6407,000 shares@ €12.80580.0022% mcap83.7% of flow
Common Stock
SEC:0001209191-21-067067·
Ideal exit: 21 Aug 2022 (T+270)
€89,6407,000 shares@ €12.80580.0022% mcap38.4% of flow
Common Stock
SEC:0001209191-21-067067:0·
Ideal exit: 21 Aug 2022 (T+270)
021,875 shares0
Common Stock
SEC:0001209191-21-058610·
021,875 shares0
Common Stock
SEC:0001209191-21-058610:0·
€16,4591,900 shares@ €8.662550.0% of flow
Common Stock
SEC:0001626199-21-000131·
Ideal exit: 20 Jun 2022 (T+270)
€16,4591,900 shares@ €8.662525.0% of flow
Common Stock
SEC:0001626199-21-000131:0·
Ideal exit: 20 Jun 2022 (T+270)
€16,4591,900 shares@ €8.662550.0% of flow
Common Stock
SEC:0001626199-21-000126·
€16,4591,900 shares@ €8.662525.0% of flow
Common Stock
SEC:0001626199-21-000126:0·
€17,4971,453 shares@ €12.04190.0004% mcap16.3% of flow
Common STock
SEC:0001209191-21-032157·
€17,4971,453 shares@ €12.04190.0004% mcap7.5% of flow
Common STock
SEC:0001209191-21-032157:0·
13 of 13 declarations
About Peetz Christopher
Christopher Peetz is the President and CEO of Mirum Pharmaceuticals, Inc. and Alpine Immune Sciences, Inc. He oversees the operations and strategy of both companies, focusing on innovation in the pharmaceutical sector. His leadership is essential for their success.
